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Abstract
Background
Adequate application of guidelines concerning non-invasive ischemia testing (NIIT) could
avoid inappropriate invasive testing in non-emergency situations. Hardly any data exists re-
garding frequency and appropriateness of diagnostic coronary angiography (CA). The aim
of this study was to evaluate the proportion and predictors of patients without NIIT prior to
elective purely diagnostic CA without therapeutic intervention.
Methods
Retrospective cross-sectional analysis of insurance claims data from 2012 and 2013. Pa-
tients<18 years, acute cardiac ischemia and emergency procedures and patients insured
in a managed care model were excluded from analysis. The proportion of patients with NIIT
procedures (stress-ECG, transthoracic echocardiography, stress echocardiography, scin-
tigraphy, computer tomography, heart MRI) undertaken within two months before diagnostic
CA was assessed. Multiple logistic regression analysis was applied to investigate indepen-
dent determinants for receiving NIIT.
Findings
2714 patients were included for analysis. 37.5% (1018) did not receive any NIIT before CA.
When high risk patients (patients having received therapeutic cardiac intervention within
one month after or 18 months prior to diagnostic CA, n = 766) were excluded 34.3% (669)
did not receive NIIT before CA. High risk status as well as>6 chronic comorbidities were in-
dependently associated with a lower proportion of NIIT (p<0.0001, OR 0.607 and p =
0.0041, OR 0.648), when additionally controlled for age, sex, language area, insurance cov-
erage, inpatient treatment, cardiovascular medication and lower number of chronic comor-
bidities. Age (p<0.05, OR 1.009) and intake of oral antiplatelet therapy (p<0.0001, OR
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1.914) were independently associated with a higher proportion of NIIT when controlled for
the mentioned cofactors.
Conclusions
Our data show that despite the existence of guidelines a substantial overuse of a potentially
harmful and inappropriate diagnostic intervention is performed suggesting the need for im-
provement of diagnostic pathways prior to invasive testing.
Introduction
Recommendations vary regarding the optimal approach to patients with suspected coronary
heart disease (CHD) in a non-emergency setting. The American Heart Association suggests
non-invasive ischemia testing (NIIT) for all patients with suspected CHD or change in clinical
status in a patient with known CHD unless unstable angina pectoris is assumed [1]. The British
(NICE) [2,3] guidelines recommend using imaging studies based on CHD risk scoring and not
stress tolerance test to exclude angina in patients with no previous history of CHD. For patients
with an estimated likelihood for CHD of 61–90% in whom stable angina cannot be diagnosed
or excluded by clinical assessment alone, invasive coronary angiography (CA) after performing
a 12-lead ECG is suggested. The European Society of Cardiology recommends no testing by
means of non-invasive methods in patients with a pre-test probability below 15% or above
85%. In such patients, either no obstructive or obstructive coronary artery can be assumed [4].
The Swiss Society of Cardiology does not publish any recommendations concerning diagnostic
pathway prior to CA except in the case of acute coronary syndrome. Adequate application of
guidelines concerning non-invasive ischemia testing could avoid inappropriate invasive testing.
Nevertheless a few studies from the U.S.A indicate that a large proportion of patients does not
undergo recommended NIIT prior to CA, raising the question whether a substantial amount of
patients might currently undergo inappropriate invasive testing with associated costs [5–8].
CA has long been considered to be the best test for the detection of CHD. Significant CHD
is postulated in case of luminal narrowing of a coronary artery of at least 50%. Concerns over
clinical usefulness of CA have been raised, since an atherosclerotic coronary artery lesion need
not be obstructive to become thrombogenic, nor do all obstructive lesions have thrombogenic
potential. Angiographic findings do not necessarily accurately predict the site of lesions that
leads to subsequent coronary artery thrombosis. Therefore coronary bypass surgery or angio-
plasty directed only at discernible stenotic lesions may not be effective for preventing subse-
quent myocardial infarctions [9]. Not only the uncertainty about clinical relevance of the
findings in CA, but also the associated risks of this intervention should be taken into consider-
ation, before invasive diagnostic testing is performed. Major complication rates have been esti-
mated between 0.1% and 3%, including procedure-related mortality, non-fatal Q wave
myocardial infarction, coronary artery spasm, severe arrhythmia, severe contrast allergic reac-
tion, retroperitoneal haemorrhage, peripheral vascular complication, acute kidney injury (con-
trast nephropathy) and heart failure [10]. Besides these major risks also minor but common
complications at the site of catheter insertion should be considered including acute thrombosis,
distal embolization, vascular dissection, poorly controlled bleeding, hematoma, pseudoaneur-
ysm or arteriovenous fistula [11–13]. Compared to CA, NIIT on the other hand has the capa-
bility of providing prognostic information by estimating the ischemic effect of a coronary
lesion and has been shown to reduce the use of CA as well as associated costs [8,14]. Utilisation
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of NIIT in combination with selective CA therefore results in optimal yield of diagnostic and
therapeutic CA.
No data exist on frequency and appropriateness of diagnostic CA in Europe. The aim of this
study was therefore to evaluate the proportion and predictors of patients without NIIT prior to
elective purely diagnostic CA without therapeutic intervention. We performed a retrospective
analysis of insurance claims data on diagnostic procedures undertaken within two months be-
fore CA.
Methods
Setting
In Switzerland, patients have mandatory health insurance, which provides unlimited access to
the health care system, including specialist care and emergency care at the hospital. Unlike
other European countries, there are no mandatory barriers (gate-keeping systems). Depending
on the insurance model chosen by the patient, annual deductibles for adults vary between 300
and 2500 Swiss Francs and access to specialists might be limited. In limited access models, such
as the managed care model for example, the general practitioner or the insurance telephone
hotline has to be consulted before contacting a specialist or another institution such as a hospi-
tal. In case of emergency this regulation is overruled.
Subjects, data collection and measurements
Data for this study included mandatory health insurance claims from approximately 1.2 mil-
lion persons which lived all over Switzerland and were enrolled with the Helsana Group, con-
sisting of four health insurance plans. Data on patients undergoing CA in the years 2012 and
2013 were retrospectively analysed.
Inclusion criteria. Purely diagnostic uncomplicated CA in adults in the years 2012 and
2013 (all patients enrolled were not treated with coronary angioplasty/stenting or coronary ar-
tery by-pass grafting):
• In-patients with SwissDRG-Code F49F (invasive cardiologic diagnostics except in acute
myocardial infarction, one hospital day stay).
• Outpatients: Tarmed positions (Standard billing rate for outpatient medical care in Swit-
zerland): 17.0710 (CA, basic service I) and/or 17.0740 (CA, arterial approach, basic service
II) and/or 17.1010 (left heart catheterization) and/or 17.1090 (selective CA) and/or
17.1810 (technical basic service 0, CA/cardiologic- interventional radiology) and/or
17.1820 (technical basic service 1, CA/cardiologic- interventional radiology).
Exclusion criteria. Emergency CA. CA was defined as emergency procedure when an
emergency Tarmed position was charged for at the same day as the procedure was performed
(positions 00.2510, 00.2520, 00.2540, 00.2560, 00.2580, 35.0610). In 198 cases this criteria
was met.
- To exclude selection bias in a health care system with no mandatory gate-keeping system,
which is the case in Switzerland, patients insured voluntarily in a managed care model were
excluded from analysis. In 2531 cases this criteria was met.
Measurements. Patient characteristics: sex, age, language area and type of insurance cov-
erage (deductible class, supplementary private hospital insurance)
- Setting of CA: inpatient or outpatient
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- Diagnostic procedures performed within two months prior to CA according to Tarmed
position:
• 17.0010: Electrocardiogram (ECG): not considered as NIIT, only in combination with
other NIIT
• 17.0050: Cardiac intervention with medication under continuous registration of ECG: not
considered as NIIT, only in combination with another NIIT
• 17.0060: ECG performed by specialist outside of the practice or hospital: not considered
as NIIT, only in combination with another NIIT
• 17.0080 and 17.0090: Stress-ECG
• 17.0210: Echocardiography, transthoracic, qualitative and quantitative examination
of adult
• 17.0280: Stressechocardiography, physical stress
• 17.0290: Stressechocardiography, medication stress
• 31.0260: Scintigraphy physiologicily triggered
• 39.4060: Computed tomography of entire thorax and/or sternoclavicular joint
• 39.5100 Heart MRI
- Cardiovascular Medication grouped according to Anatomical-Therapeutic-Chemical-Classi-
fication (ATC) [15]
• Group 1: N02BA01, B01AC (Aspirin, platelet aggregation inhibitors)
• Group 2: C10 (statins, lipid modifying agents)
• Group 3: C02, C03, C07, C08, C09 (antihypertensives, diuretics, beta blocking agents,
calcium channel blockers, agents acting on the renin-angiotensin system)
• Group 4: A10 (antidiabetics)
- Number of chronic conditions according to Pharmaceutical cost groups PCG [16]
• Group 1: 3–4 chronic diseases
• Group 2: 5–6 chronic diseases
• Group 3: more than 6 chronic diseases
Sensitivity Analysis with high risk patients. We performed a sensitivity analysis of our
data by defining a subgroup of patients as high risk patients with supposed cardiac disease
(total n = 766) if having received following therapeutic cardiac intervention/diagnosis within
one month after and/or 18 months prior to diagnostic CA:
- Up to 18 months prior to CA registered SwissDRG-Code from chapter F (diseases and dys-
function of the circulatory system) or Tarmed position 17.1110 (percutaneous transluminal
coronary angioplasty in coronary stenosis or coronary occlusion, first dilated vessel seg-
ment) or 17.1240 (angioplasty of cardiac arteries and veins, first dilated vessel) (n = 473)
- Up to one month after CA registered SwissDRG-Code from the chapter F (diseases and dys-
function of the circulatory system) or Tarmed positions 17.1110 (percutaneous transluminal
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coronary angioplasty in coronary stenosis or coronary occlusion, first dilated vessel seg-
ment) or 17.1240 or (angioplasty of cardiac arteries and veins, first dilated vessel) (n = 242)
- Combination of the two options (n = 51)
Processing and analysing data
Data was checked for eligibility and completeness and subjected to a set of predefined plausibil-
ity tests. These included checks for contradictory data, duplication and plausibility of
time measurements.
Statistical analysis
Descriptive statistical techniques were used to provide a general profile of the study population
and grouped into patients with or without NIIT. These data were presented as means in the
case of continuous variables and as percentages in case of categorical variables. Furthermore,
differences between the two groups with respect to prior NIIT in terms of demographics, insur-
ance coverage, number of chronic conditions, medication class and language area were ana-
lysed with a nonparametric analysis of variance (Kruskal-Wallis test for continuous variables
and chi-square tests for categorical variables). We developed several statistical models to evalu-
ate the major outcome of receiving NIIT within two months prior CA. In order to assess pa-
tient-level effects the following independent variable were included in the models: age, sex,
deductible class, supplementary private hospital insurance coverage, language area, inpatient
CA, cardiac medication class according to ATC, number of chronic medical conditions identi-
fied using PCGs and high risk status for CHD. The strength of associations was measured by
the odds ratio (OR) and the respective 95% confidence intervals (CI). The level of significance
was set at 0.05. All statistical analyses were performed using R version 3.1.0 (2014–04–10) (R
Foundation for Statistical Computing, Vienna, Austria).
Ethics approval
According to the national ethical and legal regulation, an ethical approval was not needed. Per-
mission to access the study data was provided by the Helsana Group. Since data was anon-
ymized, no consent of patients was required.
Results
6269 (diagnostic and therapeutic) non-emergency CA were performed in 2012 and 2013. Over-
all a total of 2714 patients met the predefined inclusion and exclusion criteria and were there-
fore included for analysis.766 of these were considered high risk patients (Table 1).
Non-invasive ischemia testing
37.5% (1018) did not receive NIIT before CA. When excluding high risk status 34.3% (669) did
not receive NIIT (Table 1). 30.1% of patients without NIIT had a conventional ECG prior to
CA, in the high risk population this was the case in 29% The most common NIIT combination
in both populations was stress-ECG + transthoracic echocardiography (22.0 and 24.0%)
(Table 2).
Determinants for non-invasive ischemia testing
Determining factors for receiving NIIT were age (p = 0.007, OR 1.011), female sex (p<0.05,
OR 1.255) and intake of oral antiplatelet therapy (p<0.001, OR 2.102). Determining factor for
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not receiving NIIT was>6 chronic comorbidities (p = 0.0018, OR 0.569). The other factors
(deductible classes, supplementary private insurance, language area, inpatient CA, ATC
Groups 2, 3 and 4, up to 6 chronic conditions) were no significant determining factors for
NIIT. When additionally controlling for high risk cardiac status, all the findings except female
Table 1. Descriptive statistics of study population.
Total Population High Risk ° Patients excluded
Total No NIIT With NIIT Total No NIIT With NIIT
Count 2714 1018 (37.5%) 1696 (62.5%) 1948 669 (34.3%) 1279(65.7%)
Age (Years) 66.1 65.4 66.6 65.3 63.7 66.2 *
Sex (Female) 1026 (37.8%) 374 (36.7%) 652 (38.4%) 762 (39.1%) 243 (36.3%) 519 (40.6%)
Deductible Class (Swiss Francs)
300 1818 (67.0%) 678 (66.6%) 1140 (67.2%) 1303 (66.9%) 447 (66.8%) 856 (66.9%)
500 640 (23.6%) 244 (24.0%) 396 (23.3%) 462 (23.7%) 159 (23.8%) 303 (23.7%)
1000 52 (1.9%) 24 (2.4%) 28 (1.7%) 40 (2.1%) 16 (2.4%) 24 (1.9%)
1500 99 (3.6%) 32 (3.1%) 67 (4.0%) 73 (3.7%) 22 (3.3%) 51 (4.0%)
2000 7 (0.3%) 3 (0.3%) 4 (0.2%) 6 (0.3%) 3 (0.4%) 3 (0.2%)
2500 98 (3.6%) 37 (3.6%) 61 (3.6%) 64 (3.3%) 22 (3.3%) 42 (3.3%)
Supplementary private insurance 711 (26.2%) 255 (25.0%) 456 (26.9%) 528 (27.1%) 178 (26.6%) 350 (27.4%)
French or Italian part of Switzerland 880 (32.4%) 323 (31.7%) 557 (32.8%) 625 (32.1%) 198 (29.6%) 427 (33.4%)
Inpatient CA 1278 (47.1%) 479 (47.1%) 799 (47.1%) 880 (45.2%) 279 (41.7%) 601 (47.0%) *
ATC_Group 1 1219 (44.9%) 366 (36.0%) 853 (50.3%) * 859 (44.1%) 220 (32.9%) 639 (50.0%) *
ATC_ Group 2 947 (34.9%) 349 (34.3%) 598 (35.3%) 643 (33.0%) 217 (32.4%) 426 (33.3%)
ATC_ Group 3 1702 (62.7%) 634 (62.3%) 1068 (63.0%) 1185 (60.8%) 396 (59.2%) 789 (61.7%)
ATC_ Group 4 403 (14.8%) 152 (14.9%) 251 (14.8%) 280 (14.4%) 91 (13.6%) 189 (14.8%)
Number of chronic conditions (PCG) 4.5 4.6 4.4 * 4.4 4.6 4.3 *
Anatomical-Therapeutic-Chemical-Classiﬁcation (ATC) group 1 = Aspirin, platelet aggregation inhibitors, Group 2 = statins, lipid modifying agents, group 3
= antihypertensives, diuretics, beta blocking agents, calcium channel blockers, agents acting on the renin-angiotensin system, group 4 = antidiabetics.
Coronary Angiography (CA). Non-invasive ischemia testing (NIIT). Pharmaceutical cost groups (PCG).
°High risk patients: having received therapeutic cardiac intervention within one month after or 18 Months prior to diagnostic CA.
*p<0.05.
doi:10.1371/journal.pone.0117172.t001
Table 2. Most common non-invasive ischemia testing performed prior to coronary angiography.
Total population High risk ° patients excluded
Total No NIIT % With NIIT % Total No NIIT % With NIIT %
Count 2714 1018 37.5 1696 62.5 1948 669 34.3 1279 65.7
Stress-ECG + Transthoracic Echocardiography 598 22.0 468 24.0
Transthoracic Echocardiography 405 14.9 282 14.5
Stress-ECG 307 11.3 244 12.5
Computer Tomography 56 2.1 40 2.1
Stress-ECG + Echocardiography + Computer Tomography 50 1.8 40 2.1
°High risk patients: having received therapeutic cardiac intervention within one month after or 18 Months prior to diagnostic CA. Electrocardiogram (ECG).
Non-invasive ischemia testing (NIIT)
doi:10.1371/journal.pone.0117172.t002
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sex remained significant. High risk patients were significantly less likely to receive NIIT
(p<0.0001, OR 0.607) (Table 3).
Discussion
In our study population of elective CA with no therapeutic consequence (no coronary angio-
plasty/stenting or coronary artery by-pass grafting) more than one third (37.5%) of patients
did not receive NIIT before diagnostic CA. When excluding high risk patients from this popu-
lation 34.3% did not receive NIIT. High risk status as well as>6 chronic comorbidities were in-
dependently associated with a lower proportion of NIIT, age and intake of oral antiplatelet
therapy with a higher proportion of NIIT.
Appropriateness of diagnostic coronary angiography
In our study emergency CA were excluded from analysis. Our study population therefore pres-
ents a selection of patients receiving elective diagnostic CA with at least stable CHD or no
CHD at all. Nevertheless an astonishing 37.5% of our patients with purely diagnostic CA not
resulting in any invasive cardiac intervention did not receive any NIIT before CA. We also
Table 3. Determinants for receiving non-invasive ischemia testing before coronary angiography, controlled for high risk patients.
OR LCI UCI Signiﬁcance
Age (Years) 1.009 1.002 1.016 0.0100 *
Sex (Female) 1.119 0.945 1.325 0.1907
Deductible Class Swiss Francs (Reference 300)
500 0.941 0.774 1.144 0.5399
1000 0.634 0.357 1.126 0.1198
1500 1.179 0.752 1.847 0.4725
2000 0.596 0.128 2.776 0.5093
2500 0.970 0.623 1.511 0.8929
Supplementary private hospital insurance 1.046 0.864 1.265 0.6454
French or Italian part of Switzerland 1.010 0.844 1.209 0.9106
Inpatient CA 0.950 0.800 1.127 0.5563
ATC_Group
1 1.914 1.610 2.275 0.0000 *
2 0.945 0.787 1.135 0.5458
3 0.944 0.791 1.126 0.5199
4 1.061 0.838 1.343 0.6206
Number of chronic conditions according to PCG (Reference 0–2)
3–4 0.968 0.757 1.237 0.7937
5–6 0.826 0.641 1.064 0.1384
>6 0.648 0.482 0.872 0.0041 *
High Risk cardiac status° 0.607 0.509 0.723 0.0001 *
Odds ratio (OR). Lower Conﬁdence Interval (LCI). Upper Conﬁdence Interval (UCI). Coronary Angiography (CA). Anatomical-Therapeutic-Chemical-
Classiﬁcation (ATC) group 1 = Aspirin, platelet aggregation inhibitors, Group 2 = statins, lipid modifying agents, group 3 = antihypertensives, diuretics,
beta blocking agents, calcium channel blockers, agents acting on the renin-angiotensin system, group 4 = antidiabetics. Pharmaceutical cost groups
(PCG).
°High risk patients: having received therapeutic cardiac intervention within one month after or 18 months prior to diagnostic CA.
*p<0.05.
doi:10.1371/journal.pone.0117172.t003
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performed a sensitivity analysis in which we excluded high risk cardiac patients from analysis.
Even in this subgroup the proportion of patients not receiving any NIIT remained high
(34.3%). To the best of our knowledge this is the first study in Europe on appropriateness of
CA. Most studies concerning the matter were performed in North America. Those data show
varying rates of NIIT prior to CA. An insurance data based US study among Medicare patients
showed a rate of 44.5% undergoing stress testing within 90 days prior to elective CA. Regional
variation was large ranging from 22.1 to 70.6% [5]. Another US study among commercially in-
sured populations showed a similar NIIT rate (only exercise stress test) to our study population
(34.4% and 29%, respectively) [7]. These large amounts of diagnostic CA without prior NIIT
found in literature as well as in our study population amaze in light of previous studies showing
that stress testing prior to CA and angioplasty has been associated with lower overall diagnostic
costs, shorter hospital stays and lower rates of revascularization, without adverse effects on car-
diac death or myocardial infarction [7,8]. It has to be assumed that the inappropriate amount
of CA in our study population could have most likely been avoided by performing NIIT prior
to invasive procedure.
Determinants for non-invasive ischemia testing
In our study female sex was initially associated with receiving NIIT prior to CA, possibly ex-
plainable by a lower pre-test probability of CHD in women. This finding was not sustainable
when controlled for high risk cardiac status. Contrary to our study female sex was associated
with a decreased likelihood of prior stress testing in the two US studies [5,7]. In those studies
also older age was associated with a decreased likelihood of prior stress testing, whereas in our
study on the contrary age was associated with a higher proportion of NIIT. Higher age repre-
sents a cardiac risk factor in the European and NICE guidelines, it would have therefore
seemed reasonable that clinicians estimated older patients being at higher risk and therefore
not performing NIIT prior to CA, according to the NICE and European guidelines. On the
other hand the US guidelines suggest always performing NIIT independent of pretest-probabil-
ity, therefore the finding of the US studies are also not consistent with their own regional
guidelines. Clinicians could have also argued being more restrictive with invasive methods in
older age, therefore rather performing NIIT. Since no other clinical data are available in our
study, the full rationale for performing NIIT or not can only be speculated upon. The intake of
oral antiplatelet therapy was also a robust determinant for receiving NIIT. This finding is diffi-
cult to interpret, since on the one hand in our study no clinical data exists, which would help
estimate the conformity to European and NICE guidelines such as chest pain characteristics.
On the other hand patients receiving an antiplatelet therapy are assumed to show a different
cardiac risk profile than patients not receiving antiplatelet therapy, such as peripheral artery or
cerebrovascular disease. Therefore physicians could have argued for immediate CA without
NIIT when following the NICE and European Guidelines suggesting no NIIT for patients with
a high cardiac risk profile. The presence of>6 comorbidities according to PCG was a robust de-
terminant for not receiving NIIT, other than a lower amount of chronic comorbidities. This
finding is similarly difficult to interpret as age, since we cannot estimate pretest probability and
therefore the rationale of the clinicians. In the two US studies [5,7] as well as in our study high
risk patients were robustly associated with decreased likelihood of NIIT. This seems to be a de-
terminant which was clearly clinically reasonable and indicates that risk stratification was per-
formed, considering the higher likelihood of a coronary pathology in patients with known
CHD.
When analysing the pattern of determinants the conclusion arises that factors must have
been involved in decision making which cannot be perceived by our study data and which
Appropriateness of Diagnostic Coronary Angiography
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probably are not part of guideline recommendations. Decision making according to perceived
risk based on patient characteristics seems tricky not only in patients with stable CHD or non-
cardiac chest pain. Lee et al have demonstrated in patients with non–ST-segment elevation
myocardial infarction that referral for CA was based on the perceived risk, rather than objective
evidence of ischemia [17]. Also in patients with stable angina evidence exists for the overesti-
mation of CHD when current algorithms for cardiac risk stratification are applied: In the study
of Cheng et al among patients which were referred for coronary computed tomographic angi-
ography, determination of pretest likelihood of angiographically significant CHD by the inva-
sive angiography-based guideline probabilities greatly overestimated the actual prevalence of
disease [18].
Guideline recommendations on diagnostic pathway
No specific type of NIIT is ideal. Depending on comorbidities the benefits of one NIIT out-
weigh the other. In the case of stable CHD only few randomized trials assessing health out-
comes for diagnostic tests exist, therefore the available evidence has been ranked according to
evidence from non-randomized studies or meta-analyses of these studies [4]. Even though the
recently updated ESC/EACTS guidelines on the management of stable angina pectoris have
downgraded the importance of stress ECG [4], a prudent approach in individuals with a suspi-
cion of CHD who can exercise and who do not have ECG abnormalities seems still to be stress
ECG testing as initial screening, when also taking easy accessibility and cost considerations
into account. Nevertheless the different existing guidelines have controversial opinions on this
matter depending on pre- and post-test probability. An exercise ECG also provides informa-
tion on exercise capacity, which may be more predictive of outcome than ST segment changes
[19,20]. International recommendations vary regarding the optimal approach to patients with
suspected CHD [1–4]. Some always suggest NIIT prior to CA, except in emergency situations.
Other base decision making on cardiac risk stratification and suggest different NIIT with or
without stress-ECG according to level of risk. All of these guidelines seem not to suffice in re-
ducing the low diagnostic yield of elective CA, as shown by Patel et al where only 37.6% of the
elective CA without known CHD showed obstructive lesions [21].
Strengths and limitations
Our study has several limitations. Our data originates from a single health insurance group in
Switzerland, although the largest in the country. This is to our best knowledge the first Europe-
an study on appropriateness of CA, especially in a non-gate-keeping health care system such as
Switzerland. Most of the literature found on the matter originated from North America. Since
this is a retrospective, observational study using administrative data, uncertainties exist con-
cerning patient selection bias and unmeasured confounders affecting the likelihood of patients
receiving NIIT. Since analyses originate in billing process, data not documented by the clini-
cians might be lacking. Also patients paying for care out of their own pocket due to a high de-
ductible and not informing the insurance about performed diagnostic measures are not
included in analysis. This proportion is likely to be neglectable, since CA always exceeds the de-
ductible. Clinical data such as smoking status, cholesterol and blood pressure levels are not
available. Lacking clinical data and therefore being able to estimate pre-test probability for
CHD limits full estimation of appropriateness of diagnostic CA according to NICE and Euro-
pean Society of Cardiology guidelines, but not according to the American Heart Association.
As a substitute for clinical data ATC and PCG are used, offering indirect information on co-
morbidities. Since the American Heart Association has recently discarded lipid target levels the
sole information whether lipid lowering medication is prescribed seems to suffice as clinical
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information [22]. PCGs represent a strength since they have been shown to directly correlate
with associated health care costs [16]. We chose a 2-Months window to assess the rate of NIIT
prior to CA, possibly missing patients who underwent expanded medical therapy before sent
to CA after medical therapy failed to improve symptoms. Nevertheless we consider our find-
ings as robust due to following considerations: Since the recorded insurance claims cover al-
most all health care invoices, the data achieve a high degree of completeness. In order to verify
the correctness of our findings we performed a sensitivity analysis by means of defining a sub-
group of patients at high cardiac risk, which included patients having received therapeutic car-
diac intervention within one month after diagnostic CA or within 18 months prior to CA
prior. This analysis did not significantly change our main findings, indicated the unjustified
large amount of patients without NIIT prior to elective CA.
Implications for health service research and policy decision makers
The increasing use and associated health care costs [5] of CA in patients with stable CHD or
non-cardiac chest pain together with the poor diagnostic yield of elective CA highlight the
need to implement and unify and possibly improve available diagnostic algorithms to reduce
inefficient and potentially ineffective care. The currently recommended algorithms based on
clinical risk stratification do not suffice in reducing the low yield of CA in a non-emergency
setting [18]. The physician consortium convened by the American Medical Association and
the Joint Commission has identified elective percutaneous coronary intervention as one of the
five unnecessary interventions which have to be aimed at reducing its use [23]. Patient selection
should hence be contrived to such an extent that benefits of the procedure outweigh the risks,
also taking associated costs into consideration. Considering that in our study population in a
non-emergency setting every third patient undergoing elective CA with no therapeutic conse-
quence had no NIIT before intervention suggests the need for more restrictive measures. A
possible solution might be that invasive cardiologic centres should demand for NIIT prior to
invasive diagnostic procedures. Less is sometimes more appropriate also in diagnostic CA, as
seen in a study showing that patients in regions providing high-intensity care do not have bet-
ter (and sometimes have worse) outcomes than those in regions providing low-intensity care
[24].
Conclusions
Our data show that despite the existence of guidelines a substantial overuse of a potentially
harmful and inappropriate diagnostic intervention is performed suggesting the need for im-
provement of diagnostic pathways prior to invasive testing.
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